GLP3 (Reta20)

Description

GLP-3 / Retatrutide – Triple Receptor Peptide 
Retatrutide (GLP-3) is an advanced triple agonist peptide targeting the GLP-1, GIP, and Glucagon receptors. Designed to deliver powerful metabolic regulation, it shows profound potential in weight loss, fat reduction, and glycemic control.

Potential Benefits:
• Significant reduction in body weight, including visceral fat and waist size
• Enhanced insulin sensitivity and improved blood sugar stability
• Increased energy expenditure and enhanced fat burning
• Improved metabolic flexibility and reductions in liver fat content
• Potential benefits exceeding those of single or dual receptor agonists

Safety & Use Notes:
This compound is for research & laboratory use only. Not for human or veterinary consumption.